This is a step toward helping people to overcome depression, anxiety, addiction, PTSD, and many other psychological disorders.

MDMA has recently been granted permission to enter Phase 3 of a clinical trial; meaning that the testing of the Drug on patients to assess efficacy, effectiveness and safety is allowed.

With that great news, the American soap company, Dr. Bronner’s, has agreed to donate $5 million to the Multidisciplinary Association for Psychedelic Studies aka “MAPS.” The donation will be spread out in $1 million increments over five years to help fund the research on the drug so that it will eventually get approved legally by the U.S Food and Drug Administration.

CEO David Bronner said recently, “There is tremendous suffering and pain that the responsible integration of MDMA for treatment-resistant PTSD will alleviate and heal. To help inspire our allies to close the funding gap, my family has pledged $1 million a year for five years – $5 million total – by far our largest gift to an NGO partner to date. In part, we were inspired by the incredible example of Ashawna Hailey, former MAPS Board member, who gave MAPS $5 million when she died in 2011.”

Currently, MDMA is classified as a Schedule 1 substance under the Controlled Substances Act of the United States, which states that the drug has “no currently accepted medical use and a high potential for abuse” thus making it illegal to possess, make or consume.

Hopefully this donation can help speed up the process of the legalization of MDMA so that people can get the help they need.

Keep up with the latest trending music news by following us on Facebook, Twitter, and Instagram.

The post $5 Million Donated Towards Mdma Medical Research appeared first on PRO MOTION Music News.